GRMN vs LPCN · P/E 28, rev $7.25B vs rev $309.5K
Garmin Ltd (GRMN) versus Lipocine Inc (LPCN) — a side-by-side from cached financials, not a winner call.
Garmin Ltd (GRMN) is a scientific & technical instruments company listed on US.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Latest reported GRMN revenue for 2025-12-27 was $7.25B. Net income was $1.66B. Revenue was up 15.1% from 2024-12-28 to 2025-12-27. GRMN currently screens at market cap $41.35B and trailing P/E 28.3.
Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.
GRMN currently screens at market cap $41.35B and trailing P/E 28.3. LPCN currently screens at market cap $19.3M.
Not investment advice. Open the GRMN and LPCN stock pages for the full models.
Not investment advice.